Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
By Hannah M. Jones, Yuan Chen, Christopher R. Gibson, T. Heimbach, Neil Parrott, S. Peters, Jan Snoeys, V. Upreti, Ming Zheng, S. Hall. Clinical pharmacology and therapy, 2015
440 citations recorded by the source corpus.
Subfields: Pharmacology, Spectroscopy, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/ebe4ba6bc3108e130ca6360dbb8c3e2445cf8c04
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Statistics and Probability
Citations in the corpus
- Computational Approaches in Preclinical Studies on Drug Discovery and Development (2020, background): “, drug concentration and clearance rate) and species physiology parameters to replicate the PK profile of a drug in plasma and tissues, aiming to describe in vivo drug pharmacokinetics that are related to tissue volume, administration routes, blood flow, biotransformation pathways, and interactions ”